Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus
Klaus Herrlinger(Robert Bosch Hospital), Klaus Fellermann(Apple (Israel)), Jan Wehkamp(Robert Bosch Hospital), K. J. Schmidt(University Hospital Schleswig-Holstein), EF Stange(Robert Bosch Hospital), Chris Barthel(Robert Bosch Hospital), Daniel Nicolas Barthel(Robert Bosch Hospital), Jürgen Büning(University Hospital Schleswig-Holstein)
Cited by 50
Related Papers
Reduced Paneth cell α-defensins in ileal Crohn's disease
|Proceedings of the National Academy of Sciences|2005|969
NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
|Gut|2004|798
A Chromosome 8 Gene-Cluster Polymorphism with Low Human Beta-Defensin 2 Gene Copy Number Predisposes to Crohn Disease of the Colon
|The American Journal of Human Genetics|2006|566